Feed/Investors/VTT Ventures

VTT Ventures

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2017-01-23

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$2.0M

across 1 round

LATEST ROUND

Series A · $2.0M · 2017-01-23

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

VTT Ventures: 1 round · Fireround

Company	Round	Amount	Announced	Role
Desentum Desentum develops novel allergen immunotherapy products aimed at treating allergies, primarily targeting birch pollen, peanuts, and cat allergies, which is purchased by patients seeking allergy relief.	Series A Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$2.0M	2017-01-23	[ PART ]